DRI Healthcare Trust Announces Acceptance by TSX of Normal Course Issuer Bid
TORONTO, Sept. 30, 2021 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) announced today the acceptance by the Toronto Stock Exchange (the “TSX”) of the Trust’s Notice of Intention to make a normal course issuer bid (the “NCIB”). Pursuant to the NCIB, the Trust proposes to purchase, from time to time, if […]
DRI Healthcare Trust Announces Acquisition of Royalty on Oracea®
– Oracea® is the only branded oral prescription medication indicated for papulopustular rosacea – TORONTO, Sept. 30, 2021 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) today announced that a wholly-owned subsidiary of DRI has acquired a royalty interest in Oracea® for a net purchase price of US$46.4 million. “We are […]
CTI BioPharma and DRI Healthcare Trust Announce up to $135 Million Debt and Royalty Transaction
– Transaction to Fund Launch and Commercialization of Pacritinib in the United States This Year Pending FDA Approval, and Future Commercialization – SEATTLE and TORONTO, Aug. 25, 2021 /CNW/ – CTI BioPharma Corp. (Nasdaq: CTIC) (CTI) and DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (DRI) today announced transactions totaling up to $135 million in funding for […]
DRI Healthcare Trust to Host Conference Call to Discuss Transaction Announcement
– Conference call to be held Wednesday, August 25, 2021 at 1:30 pm ET – TORONTO, Aug. 25, 2021 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) announced today that it will be conducting a conference call to discuss the Trust’s previously announced debt and royalty transaction with CTI BioPharma Corp. […]
DRI Healthcare Trust Reports Second Quarter 2021 Results
– Quarter highlighted by strong performance from existing pharmaceutical products portfolio – TORONTO, Aug. 5, 2021 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) today announced its results for the quarter ended June 30, 2021. The Trust’s second quarter 2021 financial statements and Management’s Discussion & Analysis have been filed […]
DRI Healthcare Trust to Host Second Quarter Earnings Call and Webcast on August 6, 2021
TORONTO, July 26, 2021 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) announced today it will hold a conference call to discuss its 2021 second quarter financial results on Friday, August 6, 2021, at 8:30 a.m. ET. The Trust will report its financial results on Thursday, August 5, 2021, after […]
DRI Healthcare Trust Reports First Quarter 2021 Results
– With IPO complete, Trust is focused on executing its business plan – TORONTO, May 10, 2021 /CNW/ – DRI Healthcare Trust (TSX: DHT.U) (TSX: DHT.UN) (“DRI” or “the Trust”) today announced its results for the period ended March 31, 2021. The Trust’s first quarter 2021 financial statements and Management’s Discussion & Analysis have been filed on […]
Notice of DRI Healthcare Trust’s 2021 First Quarter Financial Results Earnings Call and Webcast
TORONTO, April 27, 2021 /CNW/ – DRI Healthcare Trust (TSX: DHT.U) (TSX: DHT.UN) (the “Trust”) will release its 2021 first quarter financial results prior to market open on Monday, May 10, 2021. Management will host a conference call to review the financial results at 8:30 a.m. ET the same morning. All interested parties may join the […]
DRI Healthcare Trust Declares Distribution
TORONTO, ON, March 23, 2021 /CNW/ – The board of trustees of DRI Healthcare Trust (the “Trust”) (TSX: DHT.U) (TSX: DHT.UN) has approved the payment of a distribution of US$0.0167 per trust unit. The distribution will be paid on April 20, 2021 to unitholders of record at the close of business on March 31, 2021. The distribution is for the period from the closing of […]
DRI Healthcare Trust Completes Initial Public Offering
/NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES/ TORONTO, Feb. 19, 2021 /CNW/ – DRI Healthcare Trust (the “Trust”) (TSX: DHT.U) (TSX: DHT.UN), is pleased to announce the successful closing of its previously announced initial public offering (the “Offering”). Pursuant to the Offering, the Trust sold an aggregate of 36,527,000 units of […]